US Food and Drug Administration Seeks Input From Healthcare Technology Management Community on Medical Device Supply Disruption During COVID-19 Pandemic.
| Autor: | Morabito J |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Journal of clinical engineering [J Clin Eng] 2020 Oct-Dec; Vol. 45 (4), pp. 195-197. Date of Electronic Publication: 2020 Sep 18. |
| DOI: | 10.1097/JCE.0000000000000423 |
| Abstrakt: | The US Food and Drug Administration (FDA) is currently seeking information from the clinical community about existing and anticipated disruptions in the supply of medical devices related to COVID-19. This information is important to FDA's fulfillment of its mission to ensure that healthcare providers and patients have continued access to safe and effective medical products. Insights from the clinical community, including clinical engineers and biomedical equipment technicians, bring device supply issues experienced on the front lines to FDA's attention so that the FDA can develop effective strategies to prevent and mitigate medical device supply concerns in its continued response to the COVID-19 public health emergency. Here, we describe the public health impact of the clinical perspective and the type of information that the FDA is seeking regarding current or anticipated medical device supply concerns. Information about how to have your voice heard on this important matter is included at the end of this article. Competing Interests: The author declares no conflicts of interest. (Written work prepared by employees of the Federal Government as part of their official duties is, under the U.S. Copyright Act, a “work of the United States Government” for which copyright protection under Title 17 of the United States Code is not available. As such, copyright does not extend to the contributions of employees of the Federal Government.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|